Annual Cash & Cash Equivalents
$140.73 M
+$132.47 M+1604.12%
December 31, 2023
Summary
- As of February 7, 2025, TRML annual cash & cash equivalents is $140.73 million, with the most recent change of +$132.47 million (+1604.12%) on December 31, 2023.
- During the last 3 years, TRML annual cash & cash equivalents has risen by +$140.58 million (+93717.33%).
- TRML annual cash & cash equivalents is now at all-time high.
Performance
TRML Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$35.01 M
-$35.14 M-50.09%
September 1, 2024
Summary
- As of February 7, 2025, TRML quarterly cash and cash equivalents is $35.01 million, with the most recent change of -$35.14 million (-50.09%) on September 1, 2024.
- Over the past year, TRML quarterly cash and cash equivalents has dropped by -$35.14 million (-50.09%).
- TRML quarterly cash and cash equivalents is now -75.12% below its all-time high of $140.73 million, reached on December 31, 2023.
Performance
TRML Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TRML Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1604.1% | -50.1% |
| 3 y3 years | +10000.0% | - |
| 5 y5 years | +10000.0% | - |
TRML Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -75.1% | +323.9% |
| 5 y | 5-year | at high | >+9999.0% | -75.1% | +323.9% |
| alltime | all time | at high | >+9999.0% | -75.1% | +323.9% |
Tourmaline Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $35.01 M(-50.1%) |
| Jun 2024 | - | $70.15 M(-28.6%) |
| Mar 2024 | - | $98.29 M(-30.2%) |
| Dec 2023 | $140.73 M | $140.73 M(+109.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $67.08 M(-23.0%) |
| Jun 2023 | - | $87.09 M(+954.6%) |
| Dec 2022 | $8.26 M(+5405.3%) | - |
| Dec 2022 | - | $8.26 M |
| Dec 2021 | $150.00 K | - |
FAQ
- What is Tourmaline Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tourmaline Bio?
- What is Tourmaline Bio annual cash & cash equivalents year-on-year change?
- What is Tourmaline Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tourmaline Bio?
- What is Tourmaline Bio quarterly cash and cash equivalents year-on-year change?
What is Tourmaline Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of TRML is $140.73 M
What is the all time high annual cash & cash equivalents for Tourmaline Bio?
Tourmaline Bio all-time high annual cash & cash equivalents is $140.73 M
What is Tourmaline Bio annual cash & cash equivalents year-on-year change?
Over the past year, TRML annual cash & cash equivalents has changed by +$132.47 M (+1604.12%)
What is Tourmaline Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TRML is $35.01 M
What is the all time high quarterly cash and cash equivalents for Tourmaline Bio?
Tourmaline Bio all-time high quarterly cash and cash equivalents is $140.73 M
What is Tourmaline Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, TRML quarterly cash and cash equivalents has changed by -$35.14 M (-50.09%)